Avanos Medical Divests Respiratory Health Business To SunMed
Portfolio Pulse from Nabaparna Bhattacharya
Avanos Medical plans to divest its respiratory health business, including BALLARD, MICROCUFF, and endOclear product lines, to SunMed, a North American manufacturer and distributor of consumable medical devices. The deal also includes two Avanos manufacturing facilities in Mexico and R&D expertise. The transaction is expected to be completed by late 2023.
June 08, 2023 | 2:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Avanos Medical is divesting its respiratory health business to SunMed, including product lines and manufacturing facilities. The deal is expected to be completed by late 2023.
The divestiture of Avanos Medical's respiratory health business to SunMed is part of the company's ongoing three-year transformation process. While the financial terms were not disclosed, the deal includes product lines and manufacturing facilities. This news is directly related to Avanos Medical and may have a neutral impact on its stock price in the short term, as the market may view this as a strategic move to focus on other areas of the business.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100